"Have you taken a look at the 5 year chart of that stock? During 2017 it was trading at over $900!!! They must've had reverse splits "Up the old wazoo.""
I hadn't looked until you asked (don't care about them) but they had two, a 1:25 and a 1:10. They merged with Ritter in May of this year and Ritter had a drug in Phase 3 in 2017 that I guess was promising enough to get the price that high, but.... "In September 2019, we announced that our Phase 3 clinical trial of RP-G28 for LI failed to demonstrate statistical significance in its pre-specified primary and secondary endpoints."
Again, I only made reference to them because they had a few things in common with IPIX....a recent pre-IND response and a drug that had been through a couple of Phase 2 trials.
News 
Market Data 
Discover 
AI
